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then developed to remove the exposed
photoresist, which leaves the exposed
areas susceptible to chemical chrome
etch. The etch removes the unprotected
chrome. The rest of the photoresist is
then removed, by either ultraviolet or-
ganic solvent or overdevelopment. The
remaining chrome pattern is quickly ox-
idized by atmospheric exposure (typi-
cally within 30 seconds). 
The ready chrome mask is now applied
to the tissue slide and aligned manually, or
using automatic software and pre-de-
signed alignment marks. The slide plate
sandwich is then exposed to UV to destroy
the DNA of the unwanted cells. The slide
and plate are separated and the slide is
processed in a standard way to prepare for
polymerase chain reaction (PCR) and po-
tential identification of cancer sequences. 
This work was done by Lawrence A. Wade
of Caltech and Emil Kartalov, Darryl Shi-
bata, and Clive Taylor of the University of
Southern California for NASA’s Jet Propulsion
Laboratory. Further information is contained
in a TSP (see page 1).
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This invention relates to surface modi-
fication of porosified silicon (pSi) struc-
tures with poly(alkylene) glycols for the
purpose of controlled degradation of the
silicon matrix and tailored release of en-
capsulated substances for biomedical ap-
plications. The pSi structures are cur-
rently used in diverse biomedical
applications including bio-molecular
screening, optical bio-sensoring, and
drug delivery by means of injectable/
orally administered carriers and im-
plantable devices. 
The size of the pores and the surface
chemistry of the pSi structure can be con-
trolled during the microfabrication process
and thereafter. A fine regulation of the
degradation kinetics of mesoporous silicon
structures is of fundamental importance.
Polyethylene glycols (PEGs) represent the
major category of surface modifying agents
used in classical drug delivery systems and
in pharmaceutical dosage forms. PEGyla-
tion enables avoidance of RES uptake, thus
prolonging circulation time of intra-
venously injectable nanovectors. PEG mole-
cules demonstrate little toxicity and im-
munogenicity, and are cleared from the
body through the urine (molecular weight,
MW<30 kDa) or in the feces (MW>30kDa). 
The invention focuses on the possibility
of finely tuning the degradation kinetics
of the pSi nanovectors and other struc-
tures through surface conjugation of
PEGs with various backbone lengths/
MWs. To prove the concept, pSi nanovec-
tors were covalently conjugated to seven
PEGs with MW from 245 to 5,000 Da and
their degradation kinetics in physiologi-
cally relevant media (phosphate buffer
saline, PBS pH7.4, and fetal bovine
serum) was assessed by the elemental
analysis of the Si using inductive coupled
plasma atomic emission spectroscopy
(ICP-AES). The conjugation of the PEG
with lowest MW to the nanovectors surface
did not induce any change in the degrada-
tion kinetics in serum, but inhibited
degradation and consequently the release
of orthosilicic acid into buffer. When PEGs
with the longer chains were evaluated, Si
mass loss from the nanovectors was slowed
down, and the PEGylated structures were
almost fully degraded within 18–24 hours
in serum and within 48 hours in PBS. The
most dramatic effect was observed for
high MW PEGs 3,400 and 5,000 Da, which
prominently inhibited the degradation of
the systems, with complete degradation
achieved only after four days. For these
PEGs, during the early stages of the degra-
dation, there was a “lag” period of little or
no Si mass loss from the nanovector. 
The obtained profiles were in agree-
ment with the erosion of the nanovector
surface as observed by scanning electron
microscopy.
This work was done by Biana Godin Vi-
lentchouk and Mauro Ferrari of the University
of Texas Health Science Center at Houston, Bio-
medical Engineering, for Johnson Space Center.
For further information, contact the JSC Inno-
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Method for Impeding Degradation of Porous Silicon Structures
This method tailors degradation of a drug delivery system to enable controlled release of
therapeutic agents.
Lyndon B. Johnson Space Center, Houston, Texas
Although suited astronauts are cur-
rently cooled with a Liquid Cooled Ven-
tilation Garment (LCVG), which can re-
move up to 85 percent of body heat,
their effectiveness is limited because
cooling must penetrate layers of skin,
muscle, fat, bone, and tissue to reach the
bloodstream, where its effect is promi-
nent. Vasoconstriction further reduces
the effectiveness by limiting arterial flow
when exposed to cold (the frostbite re-
sponse), resulting in a time constant on
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the order of 20 minutes from applica-
tion to maximum effect. This delay can
be crucial in severe exposure to hypo- or
hyper-thermic conditions, compromis-
ing homeostasis. 
The purpose of this innovation is to
provide a lightweight, effective means of
delivering heat or cold from an external
source directly to the bloodstream. The
effectiveness of this ECCREP (External
Cooling Coupled to Reduced Extremity
Pressure) device is based on not having
to penetrate layers of skin, muscle, fat,
and tissue, thereby avoiding the thermal
lag associated with their mass and heat
capacity. This is accomplished by means
of an outer boot operating at a slightly
reduced pressure than the rest of the
body, combined with an inner boot
cooled or heated by an external source
via water or chemicals. Heat transfer
from the external source to the foot
takes place by means of circulating water
or flexible heat pipes. The envisioned
device, by applying its effect to only the
foot or hand, has minimal power, flow,
and mass requirements, making it attrac-
tive for the space/planetary operations
environment and compatible with exist-
ing or modified extra-vehicular activity
(EVA) suits, boots, and gloves. 
In the glove configuration, the de-
sign may also have the added benefit of
enhancing manual dexterity, a result of
operating at a lower pressure than cur-
rent EVA gloves. A boot configuration
is preferable to a glove because the foot
does not have any requirement for
manual dexterity. The theoretical basis
of the innovation is in the fact that heat
transfer from the human body to its sur-
roundings takes place largely in the ex-
tremities, especially the hands and feet.
When exposed to heat, for example,
large volumes of blood are directed to
the hands and feet, which act as pin fin
heat exchangers. This reaction is coun-
termanded when extreme cold is ap-
plied to the skin to remove heat, as in
the case of an LCVG, because extreme
cold sets up vasoconstriction that limits
bloodflow. 
The theoretical basis of the innova-
tion is that this countermand command
is apparently bypassed in the presence
of reduced pressure. The ECCREP de-
vice accelerates blood pooling in the
capillaries and arterioles of the hand or
foot due to reduced pressure, then ap-
plies cold or heat through an external
source to turn the limb into a “super
heat exchanger.”
The advantages of the device include
the ability to deliver heat or cold more
directly to the bloodstream, thus reduc-
ing the time lag of effectiveness; the abil-
ity to mitigate dehydration (sweat) and
electrolyte loss; the potential to increase
exercise performance and endurance
(keys to operations in EVA and counter-
measures while in orbit); and the possi-
ble mitigation of decrements in cogni-
tive, motor, and immune system
function associated with high-stress op-
erations such as ascent, entry, and land-
ing during long-duration and short-du-
ration missions. 
This work was done by Lawrence H.
Kuznetz of Johnson Space Center. Further in-
formation is contained in a TSP (see page 1).
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